Recent Updates
Recently added Catalysts
COLL

Collegium to Participate in Upcoming Investor Conferences

Key Takeaway: STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferen

Full Press Release Details

STOUGHTON, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in September:
The Janney Healthcare Conference 2019 on Monday, September 9th in New York City. Management will present at 8:15 a.m. ET and will also participate in investor meetings.
The H.C. Wainwright 21st Annual Global Investment Conference on Tuesday, September 10th in New York City. Management will present at 11:15 a.m. ET and will also participate in investor meetings.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Last updated: Sep 3, 2019